Updates on Lifestyle-Related Diseases and Bone Metabolism. Effects of therapeutic agents for lifestyle-related diseases on osteoporosis

Nobuki Hayakawa, Atsushi Suzuki

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

It has been revealed that various therapeutic agents for lifestyle-related diseases could affect bone metabolism. For example, thiazolidines, loop diuretics and warfarin would be possibly disadvantageous to bone metabolism. In many cases with lifestyle-related disease, it is necessary to take the medicine over a long term. Therefore, we should pay enough attention to bone metabolism during the selection of medicine, especially in the treatment of a high risk group for bone fracture. However, a majority of these drugs lack the evidence with randomized controlled trials for osteoporotic fracture. Further clinical research should be required to clarify the impact of each drug on osteoporosis with lifestyle-related diseases.

Original languageEnglish
Pages (from-to)1661-1669
Number of pages9
JournalClinical calcium
Volume24
Issue number11
Publication statusPublished - 01-11-2014

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Updates on Lifestyle-Related Diseases and Bone Metabolism. Effects of therapeutic agents for lifestyle-related diseases on osteoporosis'. Together they form a unique fingerprint.

  • Cite this